We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+1.17%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$47.1B
AUM Growth
-$899M
(-1.9%)
Cap. Flow
-$982M
Cap. Flow
% of AUM
-2.08%
Top 10 Holdings %
Top 10 Hldgs %
35.43%
Holding
967
New
122
Increased
219
Reduced
464
Closed
97
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$250M |
| 2 |
Starbucks
SBUX
|
+$152M |
| 3 |
CERN
Cerner Corp
CERN
|
+$122M |
| 4 |
Colgate-Palmolive
CL
|
+$87.1M |
| 5 |
Procter & Gamble
PG
|
+$77.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$456M |
| 2 |
Cisco
CSCO
|
+$392M |
| 3 |
Analog Devices
ADI
|
+$151M |
| 4 |
United Parcel Service
UPS
|
+$148M |
| 5 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$89.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.05% |
| 2 | Consumer Discretionary | 15.92% |
| 3 | Financials | 12.69% |
| 4 | Healthcare | 12.47% |
| 5 | Communication Services | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Steris
STE
$23B
| $5.89M | 0.01% |
63,118
-1,130
| -2% | -$103K |
|
477
Quanta Services
PWR
$101B
| $5.85M | 0.01% |
170,410
-183,631
| -52% | -$6.66M |
|
|
CRAY
478
DELISTED
Cray, Inc.
CRAY
| $5.85M | 0.01% |
282,468
-22,489
| -7% | -$521K |
|
479
Pediatrix Medical
MD
$2.12B
| $5.82M | 0.01% |
104,667
-28,472
| -21% | -$1.56M |
|
480
EQT Corp
EQT
$33B
| $5.8M | 0.01% |
224,476
+178,588
| +389% | +$5.13M |
|
481
Alaska Air
ALK
$5.39B
| $5.8M | 0.01% |
93,600
-18,104
| -16% | -$1.2M |
|
|
SIX
482
DELISTED
Six Flags Entertainment Corp.
SIX
| $5.77M | 0.01% |
92,713
-60,046
| -39% | -$3.92M |
|
483
Sabra Healthcare REIT
SBRA
$5.27B
| $5.75M | 0.01% |
326,043
-2,338
| -0.7% | -$41.2K |
|
|
VG
484
DELISTED
Vonage Holdings Corporation
VG
| $5.69M | 0.01% |
534,262
-134,840
| -20% | -$1.44M |
|
485
West Pharmaceutical
WST
$25.1B
| $5.61M | 0.01% |
63,511
-1,134
| -2% | -$106K |
|
|
FOLD
486
DELISTED
Amicus Therapeutics
FOLD
| $5.6M | 0.01% |
+372,437
| New | +$5.67M |
|
487
Texas Roadhouse
TXRH
$13.8B
| $5.59M | 0.01% |
+96,825
| New | +$5.56M |
|
488
Digi International
DGII
$3.13B
| $5.58M | 0.01% |
541,926
-59,244
| -10% | -$615K |
|
489
Fox Factory Holding Corp
FOXF
$861M
| $5.58M | 0.01% |
159,862
+1,621
| +1% | +$61.5K |
|
490
MYR Group
MYRG
$5.26B
| $5.57M | 0.01% |
180,675
+2,993
| +2% | +$102K |
|
|
FLIR
491
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $5.56M | 0.01% |
+111,255
| New | +$5.54M |
|
492
Arcos Dorados Holdings
ARCO
$1.7B
| $5.5M | 0.01% |
618,133
-8,442
| -1% | -$79.2K |
|
493
Cracker Barrel
CBRL
$1.26B
| $5.48M | 0.01% |
34,421
-2,541
| -7% | -$421K |
|
494
Tractor Supply
TSCO
$17.8B
| $5.43M | 0.01% |
+430,875
| New | +$6M |
|
495
Darling Ingredients
DAR
$9.85B
| $5.37M | 0.01% |
310,265
-134,295
| -30% | -$2.44M |
|
496
Stewart Information Services
STC
$2.05B
| $5.34M | 0.01% |
121,438
+1,138
| +0.9% | +$49K |
|
497
Oil States International
OIS
$523M
| $5.3M | 0.01% |
202,462
+33,545
| +20% | +$961K |
|
498
Hercules Capital
HTGC
$3.19B
| $5.11M | 0.01% |
422,602
-40,205
| -9% | -$504K |
|
499
Ovintiv
OVV
$17.2B
| $5.1M | 0.01% |
92,775
-3,934
| -4% | -$233K |
|
|
SPLK
500
DELISTED
Splunk Inc
SPLK
| $4.95M | 0.01% |
+50,286
| New | +$4.8M |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q1 2018 Portfolio in Review
As of Q1 2018, Loomis, Sayles & Company held 967 positions worth $47.1B, down 1.9% from $48B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Loomis, Sayles & Company's Q1 2018 filing shows 122 new, 219 increased, 464 reduced and 97 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 870,638 shares worth $70.6M. The largest sale was Amazon, an estimated $456M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- Loomis, Sayles & Company's largest Q1 2018 buy was BioMarin Pharmaceuticals: 870,638 shares worth $70.6M.
- Loomis, Sayles & Company added most to Regeneron Pharmaceuticals in Q1 2018, an estimated $250M increase.
- Loomis, Sayles & Company's biggest Q1 2018 reduction was Amazon, cutting an estimated $456M.
- Loomis, Sayles & Company fully exited Analog Devices in Q1 2018, selling an estimated $151M.
- Loomis, Sayles & Company's ten largest holdings make up 35% of its $47.1B portfolio in Q1 2018.
- Loomis, Sayles & Company opened 122 new positions and closed 97 in Q1 2018.
- Loomis, Sayles & Company's portfolio value fell 1.9% quarter-over-quarter to $47.1B.
Based on Loomis, Sayles & Company's 13F filing for Q1 2018, filed 11 May 2018.